$133.88 travel Payment -- Allergan (AbbVie) to Dr. Eric Sanchez
Dermatologist Eric Sanchez Received $133.88 Travel Payment from Allergan for Entresto
This page provides a detailed analysis of a $133.88 travel payment from Allergan (AbbVie) to Dr. Eric Sanchez. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $133.88 |
| Payment Type | travel |
| Payment Nature | Travel and Lodging |
| Pharmaceutical Company | Allergan (AbbVie) |
| Physician | Dr. Eric Sanchez |
| NPI Number | 1208177844 |
| Physician Specialty | Dermatology |
| Location | City, AL |
| Date of Payment | 2025-08-10 |
| Related Drug/Device | Entresto |
| Conflict Assessment | Low -- Routine |
AI-Powered Analysis of This Payment
The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.
Allergan (AbbVie) made a $133.88 travel payment to Eric Sanchez, a Dermatology specialist in City, AL. The payment was associated with Entresto. The payment of $133.88 to Dr. Eric Sanchez from Allergan (AbbVie) was for travel and lodging. This payment was associated with the drug Entresto, indicating a potential relationship with its promotion or research. The payment occurred on August 10, 2025, and was made to a dermatologist in Alabama.
Patient Guidance: What This Payment Means for You
This payment was for travel and lodging expenses related to a pharmaceutical company's product. It is important to understand how such payments might influence medical recommendations. Always discuss your treatment options with your healthcare provider and ask about alternatives.
Payment Context: Is This Amount Normal?
Travel and lodging payments are common in the pharmaceutical industry, but the context of this specific payment relative to dermatology norms for Entresto is not immediately clear without further data.
Regulatory Context: Sunshine Act Requirements
Payments to physicians by manufacturers are subject to disclosure under the Sunshine Act (part of the Affordable Care Act) to promote transparency in the healthcare industry.
Related Topics
This payment is related to the following healthcare transparency topics:
- pharmaceutical-payments
- open-payments
- physician-payments
- travel-expenses
- allergan
- entresto
- dermatology
Understanding travel Payments
Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.
Frequently Asked Questions About This Payment
What was this $133.88 payment for?
This was a travel payment of $133.88 from Allergan (AbbVie) to Eric Sanchez, categorized as "Travel and Lodging". It was associated with Entresto. The payment was reported under the Sunshine Act (CMS Open Payments).
Does Eric Sanchez accept pharmaceutical money?
Yes, Eric Sanchez received this $133.88 payment from Allergan (AbbVie). Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Eric Sanchez's full payment history on the CMS Open Payments database or on this site.
Is it legal for doctors to accept pharma payments?
Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.
Should I be concerned about this travel payment?
A travel payment of $133.88 should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.
How do I talk to my doctor about pharma relationships?
You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.
What types of pharma payments are most concerning?
Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.
Does pharma money affect what my doctor prescribes?
Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.
How does this compare to other doctors in Dermatology?
To compare this payment against Dermatology averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Dermatology physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.
What does this payment reveal about Eric Sanchez's relationship with Allergan (AbbVie)?
The payment amount is relatively small, suggesting it may cover incidental travel expenses. This $133.88 travel payment is part of the transparency data reported under the Sunshine Act.
Is this payment amount typical for Dermatology?
The payment type is 'travel', which is a common category in Open Payments data.
What should patients do after learning about this payment?
This payment was for travel and lodging expenses related to a pharmaceutical company's product. It is important to understand how such payments might influence medical recommendations.
What else should I know about this travel payment?
The specific drug mentioned, Entresto, is a cardiovascular medication, which might be relevant for dermatological conditions or research.
Related Reports
Data from CMS Open Payments. Payment does not imply wrongdoing. Consult your healthcare provider about any concerns.